Imidazol- or 1,2,4-triazol-derivatives and their use
US10323016B2 · kind B2 · utility
0Cited by
1References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 11, 2015 |
| Grant date | Jun 18, 2019 |
| Priority date | — |
| Expiry date | Jun 11, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel compounds of formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.